Akums Drugs & Pharmaceuticals Ltd

AKUMS
NSE· Healthcare
₹686.15
-0.80 (-0.12%)
Updated 07:28 am IST
52W Low · ₹409.3052W High · ₹714.70
Near 52W High
Market Cap
₹10747.00L Cr
Volume
1.65L
Prev Close
₹683.85
ISIN
INE09XN01023

VestAI Stock Score

VALUATION
Low Debt
D/E 0.06x — lean balance sheet
QUALITY
Low Quality
ROCE 8.6% — poor capital efficiency
MOMENTUM
Bullish
RSI 71.3 — strong momentum

Price Chart

SMA 20
SMA 50
SMA 200

Key Fundamentals

Q4 FY2026

P/E Ratio
42.16
ROCE
8.59%
ROE (1Y)
8.02%
D/E Ratio
0.06x
OPM
9.64%
TTM EPS
₹16.65
Dividend Yield
15.00%
Qtrly Sales
₹1,157.87 Cr
Qtrly Profit
₹84.61 Cr

Technical Signals

Quarterly Results

Revenue & Profit in ₹ Crores

Revenue Net Profit
QuarterRevenueNet ProfitOPMEPS
Q4 2026₹1,157.87₹84.619.6%₹5.53
Q3 2026₹1,159.59₹66.329.3%₹4.33
Q2 2026₹1,017.53₹40.785.6%₹2.66
Q1 2026₹1,024.03₹63.489.0%₹4.15
Q4 2025₹1,055.55₹147.625.1%₹9.64

Annual P&L

Revenue & Profit in ₹ Crores (Yearly)

Revenue Net Profit
YearRevenueNet ProfitEBITDAOPM
FY 2025₹4,071.09₹338.18₹529.117.6%
FY 2024₹4,019.68₹-4.04₹130.618.9%
FY 2023₹3,474.76₹94.86₹309.085.5%
FY 2022₹3,646.83₹-252.54₹-82.188.8%

Peer Comparison — Healthcare

Top companies in the same sector by market cap

CompanyMkt CapP/EROCEROED/EOPM
AKUMS ★₹10,747 Cr42.168.59%8.02%0.06x9.64%
SUNPHARMA₹4,27,609 Cr37.3215.73%14.72%0.06x18.90%
MAXHEALTH₹95,110 Cr66.2111.94%14.33%0.32x22.56%
AUROPHARMA₹90,029 Cr25.9412.55%9.93%0.21x15.11%
ABBOTINDIA₹57,724 Cr36.6336.14%34.46%0.04x27.01%
AJANTPHARM₹41,836 Cr39.5527.99%25.39%0.06x51.40%

Balance Sheet

All values in ₹ Crores

MetricFY 2025FY 2024FY 2023FY 2022
Total Assets₹4,113.44₹3,516.36₹3,266.53₹3,069.05
Equity₹3,047.01₹709.5₹717.19₹621.98
Total Debt₹88.21₹565.23₹619.09₹394.98
Cash₹101.19₹111.05₹51.61₹55.14
Net Debt—₹380.5₹485.37₹302.81
Working Capital₹1,380.86₹730.33₹658.59₹619.2

Shareholding Pattern

Q1 FY2027

Promoter
80.17%
FII
7.36%
DII
6.02%
Public
6.45%

Quarter-over-Quarter Trend

QuarterPromoterFIIDIIPublic
Q1 FY202780.17% ↓7.36% ↓6.02% ↓6.45% ↑
Q4 FY202684.93% ↑7.48% ↑6.12% ↓1.47% ↓
Q3 FY202675.26%1.14% ↓14.41% ↑6.45% ↓
Q2 FY202675.26%2.27% ↓9.28% ↑10.46% ↑
Q1 FY202675.26%4.24% ↓8.85% ↑8.92% ↑
Q4 FY202575.26%5.77% ↓7.39% ↑8.84% ↑
Q3 FY202575.26%6.36% ↓6.99% ↓8.64% ↑
Q2 FY202575.26%7.34%7.53%7.14%

Corporate Actions

Ex-DateActionDetails
2026-07-03
DIVIDEND
Dividend - Re 1 Per Share/Special Dividend - Rs 2 Per Share

Funds Holding This Stock

20 mutual fund schemes

1
Old Bridge Flexi Cap Fund Direct GrowthOld Bridge

2.26%

₹4 Cr

2
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct GrowthICICI_PRUDENTIAL

2.01%

₹129 Cr

3
Franklin India Opportunities Direct Fund GrowthFRANKLIN_TEMPLETON

1.52%

₹133 Cr

4
Templeton India Value Fund Direct Plan GrowthFRANKLIN_TEMPLETON

1.51%

₹31 Cr

5
Franklin India Multi Cap Fund Direct GrowthFRANKLIN_TEMPLETON

1.30%

₹63 Cr

6
Nippon India Pharma Fund Direct GrowthRELIANCE

0.92%

₹79 Cr

7
Franklin India Small Cap Fund Direct GrowthFRANKLIN_TEMPLETON

0.84%

₹117 Cr

8
ICICI Prudential ELSS Tax Saver Direct Plan GrowthICICI_PRUDENTIAL

0.66%

₹90 Cr

9
Samco Multi Cap Fund Direct GrowthSamco MF

0.45%

₹1 Cr

10
JioBlackRock Flexi Cap Fund Direct GrowthJioBlackRock

0.36%

₹11 Cr

Analyse AKUMS with Orion AI

Ask: "Is Akums Drugs & Pharmaceuticals Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About Akums Drugs & Pharmaceuticals Ltd (AKUMS) Stock

Akums Drugs & Pharmaceuticals Ltd is listed on the NSE under the Healthcare sector, Pharmaceuticals industry. ISIN: INE09XN01023. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.